Wear pink Tues Jan 13th at #JPM26 to recognize impact of women leaders & allies in bio. Wear a pink shirt, tie or socks if you don’t own a pink blazer. We had an incredible turnout at inaugural event at #JPM25 w/ pink visible throughout the streets of SF. Join group pic at 4pm #BiotechCEOSisterhood
At #JPM25, biopharma investors and innovators sounded the alarm: America drives global medical innovation, but we need other countries to step up to keep medicine affordable. Watch the video and read the transcript here:
www.nopatientleftbehind.org/protect-amer...
Leveraging CRISPR and AI to design new molecules & deliver them to cells. At our “Era of TechBio” event at #JPM25, Natasha Loder of The Economist spoke to Nobel Prize winner & CRISPR pioneer @jenniferdoudna.bsky.social, in a Keynote discussion. Watch in full here: www.youtube.com/watch?v=Eip9...
The full panel discussion from our “Era of TechBio” event at #JPM25 is online! Hear from leading voices at the intersection of investment, technology & healthcare discussing the latest wins & remaining obstacles & how breakthroughs like LLMs & AI agents are allowing us to scale. youtu.be/GM9l8Pi8CYs
“For a #TechBio company to have so many programs, it has to be powered by something that's different from how we do things today.” Chief R&D and Chief Commercial Officer Najat Khan, PhD spoke on the Fierce panel “Our AI Future” at the J.P. Morgan Healthcare Conference. #JPM25
Still inspired from the other week at JPM25!
Great to see Material Change Fellows at various events across JPM25, sharing their expertise and forging meaningful connections.
Grateful for our Fellows who bring their whole selves to make positive impact.
#JPM25 #Healthcare #Community
📍 JPM25 Healthcare Conference the other week: some of Material Change Fellows' attend and share their takeaways
• AI reshaping drug discovery and overall industry
• Women's Health gaining traction
• Strategic M&A accelerating
Read more details here, bit.ly/40Uel6F
#JPM25 #Healthcare #AI #BioTech
Catch up on all of the sessions from Endpoints at #JPM25, including conversations with former FDA Commissioner Scott Gottlieb and Nobel laureate Jennifer Doudna — visit our on-demand hub to watch now.
events.endpts.com/jpm25/on-dem...
Our #JPM25 event at the San Francisco Mint brought together thought leaders from investment, pharma & academia to answer the question asked by Chief R&D and Chief Commercial Officer Najat Khan: “Where is the era of #TechBio today?” www.youtube.com/watch?v=NXYg...
I was thrilled to present data that demonstrates that BioSuperior's novel drug delivery agent specifically targets #respiratory_therapeutics to lung tissue and improves lung function last week (January 14th) at #BiotechShowcase. #JPM25. #BioSuperior
What did Big Pharma really say at #JPM25? 🤔 I dug through Big Pharma's transcripts & slide decks to give you an insider's perspective on the key takeaways. From patent cliffs to pipeline strategies, get the analysis you won't find elsewhere:
substack-proxy.glitch.me/articles/big...
#JPM25 capped a pivotal year for Element, but there is more to come.
🧬CEO Molly He recently reflected on Element’s tremendous progress in 2024, the partnerships announced at JPM, and the exciting road ahead for #AVITI24
#Elembio #Multiomics
It’s amazing that the spirit of #JPM25 continues.
bsky.app/profile/rasu...
PitchBook analysts share their #JPM2025 takeaways, including the progression of disease diagnostics such as #MRD, noting Foresight Diagnostics as leading the way. Catch that around minute 26: bit.ly/42mBTCl #JPM25 #HealthcareInvestment #Diagnostics #Cancer
Sionna Therapeutics and Odyssey Therapeutics are the latest biotechs to try to go public, filing for IPOs at the end of #JPM25 week.
endpts.com/sionna-and-o...
JPM Healthcare Conference 2025 #JPM25 and How It's WayMo Different Than It Started venturevalkyrie.com/jpm-2025-and...
#ThisWeeksOysters at Swan’s Oyster Depot in San Francisco during #JPM25 #jpmhc25
Three kinds of Miyagis here !
Sun Rising in San Francisco for #JPM25
Busy days and nights discussiing #CRISPR #GeneEditing & #GeneTherapy
I am proud to work at a mission-driven company providing leading technology to people with diabetes. Our CEO shared what we’re up to at #JPM2025 this week. Check it out: s201.q4cdn.com/452214269/fi... #Insulet #Omnipod #TeamInsulet #Diabetes #DiabetesCare #T1D #T2D #JPM25 #medsky
#BiotechHangout today: Daphne Zohar, John Maraganore, Mike Yee, Sam Fazeli & BIO's John Crowley discuss China concerns, Biosecure, new admin, $XBI, overall sentiment & #JPM25 vibe, 3 big M&A deals, $ITCI & neuropsych challenges/opps, licensing: $GILD, $ABBV, stocks: $MRNA, $LLY, $MDGL bit.ly/40m6mxT
Home stretch of #JPM25 and all I want is to lie down and sleep.
Feeling about ready for a rapid unscheduled disassembly. #JPM25
A NJ-based subsidiary of Shionogi was awarded a $375M project from BARDA's Rapid Response Partnership group to advance development of S-892216 as a long-acting injectable to potentially help prevent Covid infections biospace.com/press-releas... #JPM25 "pre-exposure prophylaxis" #biosky #medsky
…and btdubs, can I get a round of applause for finishing up #JPM25 with the same number of emails in my inbox as I started with?
Peace, #JPM25. It’s not me it’s you.
- walked over 31 mi
- ate 1/2 bag of Cheetos for lunch
- drank 7.9 gallons of crappy coffee
- told 47 people no, we can’t find you a job
On the bright side
- up to date on email
- all meeting notes logged
- one glorious 30 min sit in Union Sq
- great reunions!
Impossible to be at all the #JPM25 talks on AI, so please chime in if you heard anyone address AI's impact on climate and water usage.
Let's say just a tiny fraction of AI startups are funded, what will the impact be during build? Concerned we are sprinting w/scissors.
While at the 43rd Annual J.P. Morgan Healthcare Conference, Moffitt and @Cryoportinc leaders celebrated a major milestone. Cryoport’s CRYOGENE will provide Moffitt's #SperosFL with state-of-the-art biorepository services.
Read more about this strategic partnership: bit.ly/40yKMaG
#JPM25 #JPMHC25
#JPM25 wraps up with over $18 billion in acquisitions, lifting the mood for the new year in the world of biotech M&As. Founding editor John Carroll distills the final 2024 numbers and takes a hopeful look on what's to come.
All told, we have 40+ takeaways and observations for you throughout the last three days of #JPM25 on our live blog.
Catch up on everything that happened this week here:
Monday: endpts.com/jpm25-day-1-...
Tuesday: endpts.com/jpm25-day-2-...
Wednesday: endpts.com/jpm25-day-3-...
